SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000819050-21-000161
Filing Date
2021-11-01
Accepted
2021-11-01 16:29:48
Documents
20
Period of Report
2021-10-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bbi-20211027.htm   iXBRL 8-K 47170
2 EX-1.1 a202111018kex11.htm EX-1.1 323310
3 EX-5.1 a202111018kex51.htm EX-5.1 17586
4 EX-99.1 a202111018kex991.htm EX-99.1 13106
5 EX-99.2 a202111018kex992.htm EX-99.2 13304
9 bbi-20211027_g1.jpg GRAPHIC 6568
10 bbilogopr.jpg GRAPHIC 3649
11 fdlogo1.jpg GRAPHIC 12234
12 image_1a.jpg GRAPHIC 43009
  Complete submission text file 0000819050-21-000161.txt   728436

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bbi-20211027.xsd EX-101.SCH 1909
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bbi-20211027_lab.xml EX-101.LAB 25154
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bbi-20211027_pre.xml EX-101.PRE 13055
13 EXTRACTED XBRL INSTANCE DOCUMENT bbi-20211027_htm.xml XML 11253
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

IRS No.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 211367588
SIC: 2836 Biological Products, (No Diagnostic Substances)